Amphastar Pharmaceuticals has seen significant growth since its 2014 IPO, with its stock price increasing over 500% to $45 per share.The acquisition of Baqsimi from Eli Lilly is a key revenue driver, ...
Source LinkAmphastar Pharmaceuticals has seen significant growth since its 2014 IPO, with its stock price increasing over 500% to $45 per share.The acquisition of Baqsimi from Eli Lilly is a key revenue driver, ...
Source Link
Comments